drugset / Trial / NCT07428616
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.
Timeline
- Start
- 2026-05-21
- Primary completion
- 2028-02-29
- Completion
- 2029-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zanzalintinib | Small molecule | — | — |